GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / FabGennix / Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody / Product Detail : Glut-101AP Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody
#Glut-101AP Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody
Product name : Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody
Catalog number : Glut-101AP
Supplier name : FabGennix
Data sheet: Ask more or other datasheet now !
About this Product :Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody .
Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody rabbit polyclonal These antibodies are very stable and can be stored up to 2 months at fridge temperature under 10C. Do not freeze taw, rather use Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody from the fridge if your use is less than 1 or 2 weeks.
More Details about
Thirteen types of glucose transport carrier proteins designated as Glut 1-13 facilitate glucose transport across the cell membrane. Molecular cloning of glucose transporters have identified a family of closely related genes that encodes at least 7 proteins exhibiting high degree of amino acid homology (45%-65%) all in the molecular weight range of 40-60 kDa. Individual members of the Glut family have predicted secondary structure characteristic of 12 membrane spanning domains of other transport carriers. Majority of the differences in sequence homology in Glut proteins occur at 4 hydrophilic domains that may play a role in distinct tissue-specific pattern of expression and targeting. All Glut proteins are glycosylated at or near the C-terminus and are present on either cell surface or in intracellular sites. Some transporters exhibit dynamic trafficking between intracellular storage sites and plasma membranes in response to various stimuli. In some tissues Glut proteins are asymmetrically distributed between apical and basolateral membranes as in blood brain barrier and blood testis barriers.
For research use only, not for diagnostic or therapeutic use.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Glucose Transporter Type 1, Host species: Rabbit, Polyclonal antibody
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1350: Type II interferon signaling (IFNG)
WP2344: vitamin B6 (pyridoxine, pyridoxal, pyridoxamine) biosynthesis and salvage pathway
WP2347: vitamin B5 (pantothenate) and CoA biosynthesis Pathway
WP2349: vitamin B3 (niacin), NAD and NADP biosynthesis pathway
WP100: Glutathione metabolism
WP1016: Wnt Signaling Pathway
WP1017: Type II interferon signaling (IFNG)
WP1039: Glutathione metabolism
WP104: Alanine and aspartate metabolism
WP1056: Complement and Coagulation Cascades
WP106: Alanine and aspartate metabolism
WP109: UDP-Glucose Conversion
WP1126: Tryptophan metabolism
WP1135: Wnt Signaling Pathway
WP1136: Type II interferon signaling (IFNG)
WP1172: Complement and Coagulation Cascades
WP1253: Type II interferon signaling (IFNG)
WP1289: Type II interferon signaling (IFNG)
WP1313: Insulin Signaling
WP1315: IL-5 Signaling Pathway
WP1318: Eicosanoid Synthesis
WP1321: Myometrial Relaxation and Contraction Pathways
WP1323: EGFR1 Signaling Pathway
WP1330: estrogen signalling
Related Genes :
[SLC2A1 GLUT1] Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)
[G6PD] Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 184.108.40.206)
[G6PC G6PT] Glucose-6-phosphatase (G-6-Pase) (G6Pase) (EC 220.127.116.11) (Glucose-6-phosphatase alpha) (G6Pase-alpha)
[SLC37A4 G6PT G6PT1 PRO0685 TRG19] Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19)
[GPI] Glucose-6-phosphate isomerase (GPI) (EC 18.104.22.168) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[GALT] Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 22.214.171.124) (UDP-glucose--hexose-1-phosphate uridylyltransferase)
[SLC2A4 GLUT4] Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)
[G6PC3 UGRP] Glucose-6-phosphatase 3 (G-6-Pase 3) (G6Pase 3) (EC 126.96.36.199) (Glucose-6-phosphatase beta) (G6Pase-beta) (Ubiquitous glucose-6-phosphatase catalytic subunit-related protein)
[HSPA5 GRP78] 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP)
[FBN1 FBN] Fibrillin-1 [Cleaved into: Asprosin]
[Slc2a4 Glut-4 Glut4] Solute carrier family 2, facilitated glucose transporter member 4 (GT2) (Glucose transporter type 4, insulin-responsive) (GLUT-4)
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 188.8.131.52) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[Slc2a4 Glut-4 Glut4] Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)
[ptsG glcA umg b1101 JW1087] PTS system glucose-specific EIICB component (EIICB-Glc) (EII-Glc) [Includes: Glucose permease IIC component (PTS system glucose-specific EIIC component); Glucose-specific phosphotransferase enzyme IIB component (EC 184.108.40.206) (PTS system glucose-specific EIIB component)]
[PGM2 GA-5 GAL5 YMR105C YM9718.04C] Phosphoglucomutase 2 (PGM 2) (EC 220.127.116.11) (D-glucose-1,6-diphosphate:D-glucose-1-phosphate phosphotransferase) (Glucose phosphomutase 2)
[RHM2 MUM4 At1g53500 F22G10.13 T3F20.18] Trifunctional UDP-glucose 4,6-dehydratase/UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose-reductase RHM2 (NDP-rhamnose synthase) (Protein MUCILAGE-MODIFIED 4) (Protein RHAMNOSE BIOSYNTHESIS 2) (Rhamnose biosynthetic enzyme 2) (AtRHM2) (UDP-L-rhamnose synthase MUM4) [Includes: UDP-glucose 4,6-dehydratase (EC 18.104.22.168); UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose 4-keto-reductase (EC 1.1.1.-) (EC 5.1.3.-)]
[Slc2a1 Glut-1 Glut1] Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (GT1)
[SLC5A1 NAGT SGLT1] Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1)
[PDX1 IPF1 STF1] Pancreas/duodenum homeobox protein 1 (PDX-1) (Glucose-sensitive factor) (GSF) (Insulin promoter factor 1) (IPF-1) (Insulin upstream factor 1) (IUF-1) (Islet/duodenum homeobox-1) (IDX-1) (Somatostatin-transactivating factor 1) (STF-1)
[SIRT1 SIR2L1] NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
[UGP2 UGP1] UTP--glucose-1-phosphate uridylyltransferase (EC 22.214.171.124) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase)
[gdh] Glucose 1-dehydrogenase (GDH) (GlcDH) (EC 126.96.36.199) (Aldose 1-dehydrogenase [NAD(P)(+)]) (EC 188.8.131.529) (Galactose 1-dehydrogenase) (EC 184.108.40.206) (EC 220.127.116.11)
[RHM1 ROL1 At1g78570 T30F21.10] Trifunctional UDP-glucose 4,6-dehydratase/UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose-reductase RHM1 (Protein REPRESSOR OF LRX1 1) (Rhamnose biosynthetic enzyme 1) (AtRHM1) [Includes: UDP-glucose 4,6-dehydratase (EC 18.104.22.168); UDP-4-keto-6-deoxy-D-glucose 3,5-epimerase/UDP-4-keto-L-rhamnose 4-keto-reductase (EC 1.1.1.-) (EC 5.1.3.-)]
[zwf] Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 22.214.171.124)
[UFGT AlUFGT1 AlUFGT2 FlUFGT1 FlUFGT2 ITUFGT1 ITUFGT2 RUUFGT1 RUUFGT2 VVGT1 GSVIVT00014047001 LOC100233099 VITISV_008354] Anthocyanidin 3-O-glucosyltransferase 2 (EC 126.96.36.199) (Flavonol 3-O-glucosyltransferase) (UDP-glucose flavonoid 3-O-glucosyltransferase)
[Gpi Gpi1] Glucose-6-phosphate isomerase (GPI) (EC 188.8.131.52) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)
[HXK1 GIN2 At4g29130 F19B15.160] Hexokinase-1 (EC 184.108.40.206) (Protein GLUCOSE INSENSITIVE 2)
[Sirt1 Sir2l1] NAD-dependent protein deacetylase sirtuin-1 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
[G6PC2 IGRP] Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 220.127.116.11) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein)
 Topical vaccination with super-stable ready to use nanovesicles.
 l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis.
 Flash Glucose Monitoring is associated with improved glycaemic control but use is largely limited to more affluent people in a UK diabetes centre.
 Altered walking strategy and increased unsteadiness in participants with impaired glucose tolerance and type 2 diabetes relates to small-fibre neuropathy but not vitamin D deficiency.
 The Effect of Epidural Levobupivacaine and Fentanyl on Stress Response and Pain Management in Patients Undergoing Percutaneous Nephrolithotomy.
 Differences in Beef Quality between Angus (Bos taurus taurus) and Nellore (Bos taurus indicus) Cattle through a Proteomic and Phosphoproteomic Approach.
 Inhibition of voltage-dependent potassium channels mediates cAMP-potentiated insulin secretion in rat pancreatic β cells.
 PARK2-dependent mitophagy induced by acidic postconditioning protects against focal cerebral ischemia and extends the reperfusion window.
 Discovery of a novel series of orally bioavailable and CNS penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) non-competitive antagonists based on a 1,3-disubstituted-7-aryl-5,5-bis(trifluoromethyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione core.
 RETRACTED: Bosentan attenuates cardiac fibrosis in diabetic mice without affecting blood glucose.
Enter catalog number :